西洛他唑治疗预防2型糖尿病合并冠状动脉粥样硬化患者不良心血管事件:ESCAPE研究的长期随访
Abstract Background Previously, in the ESCAPE study, a randomized controlled trial, we found that 12 months of cilostazol administration significantly decreased coronary artery stenosis and the noncalcified plaque component compared with aspirin. The goal of the current study was to evaluate the eff...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Journal of Diabetes |
Subjects: | |
Online Access: | https://doi.org/10.1111/1753-0407.13300 |